Insider selling
Traded Mar 31, 2025 · filed 2 days laterNot reported under a pre-arranged trading plan
AbbVie's CHIEF COMMERCIAL OFFICER sold $5.38M of AbbVie shares. The filing does not indicate a pre-arranged trading plan.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Feb 28, 2025 · Filed Mar 4, 2025
AbbVie's GC AND SECRETARY sold $75K of AbbVie shares. The filing says it was made under a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market sale
Code S — open-market or private sale
~$75,210
Shares × reported transaction price
28 days after results of Jan 31, 2025, 34 days before results of Apr 3, 2025
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Filing box checked: sold under a Rule 10b5-1 plan
Only flagged when a footnote says so; never inferred
FDA approved Emblaveo on Feb 7, 2025, 21 days before this trade.
New drug application approved. Active ingredient: Avibactam Sodium, Aztreonam. From openFDA. Dates only; no link between the two is implied
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +0.3% | −4.2% | +4.4% |
| 30 days | −11.6% | −13.3% | +1.7% |
| 90 days | −11.5% | +2.2% | −13.7% |
| 180 days | +0.2% | +9.8% | −9.6% |
| 365 days | +9.8% | +16.9% | −7.0% |
Past results only. Not a forecast.
Insider selling
Traded Mar 31, 2025 · filed 2 days laterNot reported under a pre-arranged trading plan
AbbVie's CHIEF COMMERCIAL OFFICER sold $5.38M of AbbVie shares. The filing does not indicate a pre-arranged trading plan.
Insider selling
Traded Mar 31, 2025 · filed 2 days laterNot reported under a pre-arranged trading plan
AbbVie's CHIEF COMMERCIAL OFFICER sold $6.98M of AbbVie shares. The filing does not indicate a pre-arranged trading plan.
Congress
Traded Feb 25, 2025 · disclosed 30 days later
8 different filers disclosed ABBV within 90 days.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.